Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid

World Journal of Gastroenterology

Volumn 9, Issue 2, 2003, Pages 316-319

  Liu, Wen Bin ^a   Yang, Chang Qing ^a   Jiang, Wei ^a   Wang, Yi Qing ^a   Guo, Jing Sheng ^a   He, Bo Ming ^a   Wang, Ji Yao ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE; COMPLEMENTARY DNA; FLUORESCEIN ISOTHIOCYANATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PRONASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL SELECTION; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; EUKARYOTIC CELL; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; LIVER; LIVER CELL; LIVER FIBROSIS; MALE; MYOFIBROBLAST; NONHUMAN; NORTHERN BLOTTING; NUCLEIC ACID PROBE; PHENOTYPE; PLASMID; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; RECOMBINANT DNA TECHNOLOGY; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; WESTERN BLOTTING;

EID: 0037442273     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i2.316     Document Type: Article

References (32)

1. Huang ZG, Zhai WR, Zhang YE, Zhang XR. Study of heteroserum-induced rat liver fibrosis model and its mechanism. World J Gastroenterol 1998; 4: 206-209
2. Jia JB, Han DW, Xu RL, Gao F, Zhao LF, Zhao YC, Yan JP, Ma XH. Effect of endotoxin on fibronectin synthesis of rat primary cultured hepatocytes. World J Gastroenterol 1998; 4: 329-331
3. Du WD, Zhang YE, Zhai WR, Zhou XM. Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol 1999; 5: 397-403
4. Cheng ML, Wu YY, Huang KF, Luo TY, Ding YS, Lu YY, Liu RC, Wu J. Clinical study on the treatment of liver fibrosis due to hepatitis B by IFN-α1 and traditional medicine preparation. World J Gastroenterol 1999; 5: 267-269
5. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835
6. Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol 1998; 29: 836-847
7. Pinzari M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver 1998; 18: 2-13
8. Brenner DA. Signal transduction during liver regeneration. J Gastroenterol Hepatol 1998; 13 (Suppl): S93-95
9. Torres L, Garcia-Trevijano ER, Rodriguez JA, Carretero MV, Bustos M, Fernandez E, Eguinoa E, Mato JM, Avila MA. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: A new role for homocysteine in liver fibrosis. Biochim Biophys Acta 1999; 1455: 12-22
10. George DK, Ramm GA, Walker NI, Powell LW, Crawford DH. Elevated serum type IV collagen: A sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol 1999; 31: 47-52
11. Murawaki Y, Ikuta Y, Idobe Y, Kawasaki H. Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis. J Gastroenterol Hepatol 1999; 14: 138-145
12. Arthur MJ, Iredale JP, Mann DA. Tissue inhibitors of metalloproteinases: Role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res 1999; 23: 940-943
13. Sakaida I, Uchida K, Hironaka K, Okita K. Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis. J Gastroenterol 1999; 34: 376-377
14. Murawaki Y, Ikuta Y, Kawasaki H. Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1. Clin Chim Acta 1999; 281: 109-120
15. Roeb E, Purucker E, Breuer B, Nguyen H, Heinrich PC, Rose-John S, Matern S. TIMP expression in toxic and cholestatic liver injury in rat. J Hepatology 1997; 27: 535-544
16. Geisler S, Lichtinghagen R, Boker KH, Veh RW. Differential distribution of five members of the matrix metalloproteinase family and one inhibitor (TIMP-1) in human liver and skin. Cell Tissue Res 1997; 289: 173-183
17. Friedmann SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250
18. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835
19. Arthur MJ, Mann DA, Iredale JP. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis. J Gastroenterol Hepatol 1998; 13 (Supp): S33-38
20. Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ, Clark N, Murphy G. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996; 24: 176-184
21. Alcolado R, Arthur MJ, Iredale JP. Pathogenesis of liver fibrosis. Clin Sci (Lond) 1997; 92: 103-112
22. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self-perpetuation in liver fibrogenesis. J Clin Invest 1992; 89: 19-27
23. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996; 110: 821-831
24. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 2000; 32: 1248-1254
25. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-549
26. Nie QH, Cheng YQ, Xie YM, Zhou YX, Cao YZ. Inhibiting effect of antisense oligonucleotides phosphortioate on gene expression of TIMP-1 in rat liver fibrosis. World J Gastroenterol 2001; 7: 363-369
27. Louis H, Le Moine A, Quertinmont E, Peny MO, Geerts A, Goldman M, Le Moine O, Deviere J. Repeated concanavalin A challenge in mice induces an interleukin 10-producing pherotype and liver fibrosis. Hepatology 2000; 31: 381-390
28. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992; 14: 455-463.
29. Kovalovich K, DeAngelis RA, Li W, Furth ED, Ciliberto G, Taub R. Increased toxin induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31: 149-159
30. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: A review. Semin Liver Dis 1990; 10: 56-65
31. Arthur MJ. Collagenases and liver fibrosis. J Hepatol 1995; 22: S43-48
32. Arthur MJ. Degradation of matrix proteins in liver fibrosis. Pathol Res Pract 1994; 190: 825-833